Emerging Mechanistic Links Between Fucosylation and Senescence in Lung Diseases

Snehalakshmi Kavacheri Subramaniam , Minxuan Hu , Wenjing Gu , Angle Xu , Peisong Gao

J. Respir. Biol. Transl. Med. ›› 2026, Vol. 3 ›› Issue (2) : 10005

PDF (1386KB)
J. Respir. Biol. Transl. Med. ›› 2026, Vol. 3 ›› Issue (2) :10005 DOI: 10.70322/jrbtm.2026.10005
Review
research-article
Emerging Mechanistic Links Between Fucosylation and Senescence in Lung Diseases
Author information +
History +
PDF (1386KB)

Abstract

Cellular senescence is increasingly recognized as a key driver of chronic lung diseases, contributing to persistent inflammation, impaired tissue repair, and pathological remodeling. In parallel, aberrant protein fucosylation has emerged as an important regulator of epithelial function and immune signaling in the respiratory tract. Recent evidence suggests that these processes may be mechanistically linked rather than independently dysregulated. In particular, core fucosylation mediated by fucosyltransferases, such as fucosyltransferases 8 (FUT8), can modulate receptor activity and amplify signaling pathways, including TGF-β/Smad and PI3K/Akt, that are central to the induction and maintenance of cellular senescence. These interactions may promote epithelial dysfunction, the senescence-associated secretory phenotype (SASP) production, and pro-fibrotic remodeling in diseases such as COPD, asthma, and idiopathic pulmonary fibrosis. In this review, we synthesize current knowledge on cellular senescence and fucosylation in chronic lung disease and highlight emerging evidence linking these processes through shared signaling networks. We further discuss the potential of the fucosylation-senescence axis as a source of novel biomarkers and therapeutic targets. This review is among the first to integrate emerging evidence linking aberrant fucosylation with cellular senescence signaling in chronic lung diseases, thereby providing a conceptual framework for future mechanistic and translational studies.

Keywords

Cellular senescence / Glycosylation / Fucosylation / Fucosyltransferases / SASP / asthma / COPD / IPF

Cite this article

Download citation ▾
Snehalakshmi Kavacheri Subramaniam, Minxuan Hu, Wenjing Gu, Angle Xu, Peisong Gao. Emerging Mechanistic Links Between Fucosylation and Senescence in Lung Diseases. J. Respir. Biol. Transl. Med., 2026, 3 (2) : 10005 DOI:10.70322/jrbtm.2026.10005

登录浏览全文

4963

注册一个新账户 忘记密码

Author Contributions

S.K.S., W.G., M.H., A.X. and P.G. collected data and wrote the manuscript. All authors read and approved the final version of the manuscript.

Ethics Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No datasets were generated or analyzed during the current study.

Funding

We gratefully acknowledge the support of Grants from the US National Institutes of Health (NIH) (1R01AI153331 and R01AI141642).

Declaration of Competing Interest

The authors have declared that no conflict of interest exists.

References

[1]

Wan R, Srikaram P, Guntupalli V, Hu C, Chen Q, Gao P. Cellular senescence in asthma: from pathogenesis to therapeutic challenges. eBioMedicine 2023, 94, 104717. DOI: 10.1016/j.ebiom.2023.104717

[2]

Saito Y, Yamamoto S, Chikenji TS. Role of cellular senescence in inflammation and regeneration. Inflamm. Regener. 2024, 44, 28. DOI: 10.1186/s41232-024-00342-5

[3]

Correia-Melo C, Hewitt G, Passos JF . Telomeres, oxidative stress and inflammatory factors: partners in cellular senescence? Longev. Healthspan 2014, 3, 1. DOI: 10.1186/2046-2395-3-1

[4]

Di Micco R, Krizhanovsky V, Baker D, d’Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat. Rev. Mol. Cell. Biol. 2021, 22, 75-95. DOI: 10.1038/s41580-020-00314-w

[5]

Santoro A, Bientinesi E, Monti D. Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?. Ageing Res. Rev. 2021, 71, 101422. DOI: 10.1016/j.arr.2021.101422

[6]

Shvedova M, Samdavid Thanapaul RJR, Thompson EL, Niedernhofer LJ, Roh DS. Cellular Senescence in Aging, Tissue Repair, and Regeneration. Plast. Reconstr. Surg. 2022, 150, 4S-11S. DOI: 10.1097/PRS.0000000000009667

[7]

Muñoz-Espín D, Cañamero M, Maraver A, Gómez-López G, Contreras J, Murillo-Cuesta S, et al. Programmed Cell Senescence during Mammalian Embryonic Development. Cell 2013, 155, 1104-1118. DOI: 10.1016/j.cell.2013.10.019

[8]

Wang X, Qu M, Li J, Danielson P, Yang L, Zhou Q. Induction of Fibroblast Senescence During Mouse Corneal Wound Healing. Investig. Ophthalmol. Vis. Sci. 2019, 60, 3669. DOI: 10.1167/iovs.19-26983

[9]

Calcinotto A, Kohli J, Zagato E, Pellegrini L, Demaria M, Alimonti A. Cellular Senescence: Aging, Cancer, and Injury. Physiol. Rev. 2019, 99, 1047-1078. DOI: 10.1152/physrev.00020.2018

[10]

Vicente R, Mausset-Bonnefont AL, Jorgensen C, Louis-Plence P, Brondello JM . Cellular senescence impact on immune cell fate and function. Aging Cell 2016, 15, 400-406. DOI: 10.1111/acel.12455

[11]

Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011, 479, 547-551. DOI: 10.1038/nature10599

[12]

Lecot P, Alimirah F, Desprez PY, Campisi J, Wiley C. Context-dependent effects of cellular senescence in cancer development. Br. J. Cancer 2016, 114, 1180-1184. DOI: 10.1038/bjc.2016.115

[13]

Yamamoto-Imoto H, Minami S, Shioda T, Yamashita Y, Sakai S, Maeda S, et al. Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis. Cell Rep. 2022, 38, 110444. DOI: 10.1016/j.celrep.2022.110444

[14]

Moiseeva V, Cisneros A, Sica V, Deryagin O, Lai Y, Jung S, et al. Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration. Nature 2023, 613, 169-178. DOI: 10.1038/s41586-022-05535-x

[15]

Bateman G, Guo-Parke H, Rodgers AM, Linden D, Bailey M, Weldon S, et al. Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis. Biomedicines 2023, 11, 2072. DOI: 10.3390/biomedicines11072072

[16]

Yao H, Chung S, Hwang JW, Rajendrasozhan S, Sundar IK, Dean DA, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J. Clin. Investig. 2012, 122, 2032-2045. DOI: 10.1172/JCI60132

[17]

Aghali A, Khalfaoui L, Lagnado AB, Drake LY, Teske JJ, Pabelick CM, et al. Cellular senescence is increased in airway smooth muscle cells of elderly persons with asthma. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2022, 323, L558-L568. DOI: 10.1152/ajplung.00146.2022

[18]

Yang T, Wan R, Tu W, Avvaru SN, Gao P. Aryl hydrocarbon receptor: Linking environment to aging process in elderly patients with asthma. Chin. Med. J. 2024, 137, 382-393. DOI: 10.1097/CM9.0000000000002960

[19]

Chen Z, Gu W, Wan R, Zeng Y, Xiang X, Ouyang R, et al. Epithelial AhR Suppresses Allergen-Induced Oxidative Stress and Senescence via c-Myc Regulation. Antioxidants 2025, 15, 22. DOI: 10.3390/antiox15010022

[20]

Gu W, Wan R, Chen Z, Wang W, Xie S, Hao C, et al. PPAR-γ suppresses macrophage senescence and allergic airway inflammation through controlling lipid metabolic pathways. eBioMedicine 2026, 126, 106226. DOI: 10.1016/j.ebiom.2026.106226

[21]

Yuan X, Zhong W, Xie S, Liu L, Gu W, Zeng Y, et al. Oxidative Stress and PRKN-Mediated Senescence Link RhoA/ROCK Signaling to Epithelial Remodeling in Allergic Rhinitis. Antioxidants 2026, 15, 77. DOI: 10.3390/antiox15010077

[22]

Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, et al. Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun. 2017, 8, 14532. DOI: 10.1038/ncomms14532

[23]

Roger I, Milara J, Belhadj N, Cortijo J . Senescence Alterations in Pulmonary Hypertension. Cells 2021, 10, 3456. DOI: 10.3390/cells10123456

[24]

Zhang L, Pitcher LE, Prahalad V, Niedernhofer LJ, Robbins PD. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J. 2023, 290, 1362-1383. DOI: 10.1111/febs.16350

[25]

Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Sig. Transduct. Target. Ther. 2023, 8. DOI: 10.1038/s41392-023-01502-8

[26]

Huang W, Hickson LJ, Eirin A, Kirkland JL, Lerman LO. Cellular senescence: the good, the bad and the unknown. Nat. Rev. Nephrol. 2022, 18, 611-627. DOI: 10.1038/s41581-022-00601-z

[27]

Schuliga M, Read J, Knight DA. Ageing mechanisms that contribute to tissue remodeling in lung disease. Ageing Res. Rev. 2021, 70, 101405. DOI: 10.1016/j.arr.2021.101405

[28]

Ohtsubo K, Marth JD. Glycosylation in Cellular Mechanisms of Health and Disease. Cell 2006, 126, 855-867. DOI: 10.1016/j.cell.2006.08.019

[29]

Goto Y, Uematsu S, Kiyono H. Epithelial glycosylation in gut homeostasis and inflammation. Nat. Immunol. 2016, 17, 1244-1251. DOI: 10.1038/ni.3587

[30]

He M, Zhou X, Wang X. Glycosylation: mechanisms, biological functions and clinical implications. Sig. Transduct. Target. Ther. 2024, 9, 194. DOI: 10.1038/s41392-024-01886-1

[31]

Bengtsson E, Lindblom K, Tillgren V, Aspberg A. The leucine-rich repeat protein PRELP binds fibroblast cell-surface proteoglycans and enhances focal adhesion formation. Biochem. J. 2016, 473, 1153-1164. DOI: 10.1042/BCJ20160095

[32]

Lin B, Qing X, Liao J, Zhuo K. Role of Protein Glycosylation in Host-Pathogen Interaction. Cells 2020, 9, 1022. DOI: 10.3390/cells9041022

[33]

Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. Mucins in Intestinal Mucosal Defense and Inflammation: Learning from Clinical and Experimental Studies. Front. Immunol. 2020, 11, 2054. DOI: 10.3389/fimmu.2020.02054

[34]

Kudelka MR, Stowell SR, Cummings RD, Neish AS. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 597-617. DOI: 10.1038/s41575-020-0331-7

[35]

Wolfert MA, Boons GJ. Adaptive immune activation: glycosylation does matter. Nat. Chem. Biol. 2013, 9, 776-784. DOI: 10.1038/nchembio.1403

[36]

Pinho SS, Alves I, Gaifem J, Rabinovich GA. Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection. Cell. Mol. Immunol. 2023, 20, 1101-1113. DOI: 10.1038/s41423-023-01074-1

[37]

Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat. Rev. Nephrol. 2019, 15, 346-366. DOI: 10.1038/s41581-019-0129-4

[38]

Li Y, Wu R, Tian X, Zhang M, Cheng Z. Bioinformatics Analysis and Experimental Validation to Identify Key Glycosylation-Related Genes in Asthma. JIR 2024, 17, 9469-9484. DOI: 10.2147/JIR.S484542

[39]

Ghirardello M, Yruela I, Merino P, Sackstein R, Sanz-Martínez I, Hurtado-Guerrero R. Structure, function, and implications of fucosyltransferases in health and disease. Nat. Commun. 2025, 16, 11279. DOI: 10.1038/s41467-025-66871-w

[40]

Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, et al. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney Int. 2020, 97, 340-349. DOI: 10.1016/j.kint.2019.08.022

[41]

Ghorashi AC, Boucher A, Archer-Hartmann SA, Zalem D, Taherzadeh Ghahfarrokhi M, Murray NB, et al. Fucosylation of glycoproteins and glycolipids: opposing roles in cholera intoxication. Nat. Chem. Biol. 2025, 21, 555-566. DOI: 10.1038/s41589-024-01748-5

[42]

Kizuka Y. The last piece in fucosylation. Nat. Chem. Biol. 2025, 21, 470-471. DOI: 10.1038/s41589-025-01850-2

[43]

Jiang Y, Wang Z, Hu J, Wang W, Zhang N, Gao L. Core fucosylation regulates alveolar epithelial cells senescence through activating of transforming growth factor-β pathway in pulmonary fibrosis. Aging 2023, 15, 9572-9589. DOI: 10.18632/aging.205036

[44]

Duan C, Wu J, Wang Z, Hou X, Han C. Fucosylation in digestive inflammatory diseases and cancers: From mechanical studies to clinical translation. Genes Dis. 2025, 12, 101570. DOI: 10.1016/j.gendis.2025.101570

[45]

Schneider M, Al-Shareffi E, Haltiwanger RS. Biological functions of fucose in mammals. Glycobiology 2017, 27, 601-618. DOI: 10.1093/glycob/cwx034

[46]

Scott DW, Tolbert CE, Graham DM, Wittchen E, Bear JE, Burridge K. N-glycosylation controls the function of junctional adhesion molecule-A. MBoC 2015, 26, 3205-3214. DOI: 10.1091/mbc.e14-12-1604

[47]

Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, Golovkina TV, et al. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 2014, 514, 638-641. DOI: 10.1038/nature13823

[48]

Yoo JS, Oh SF. Unconventional immune cells in the gut mucosal barrier: regulation by symbiotic microbiota. Exp. Mol. Med. 2023, 55, 1905-1912. DOI: 10.1038/s12276-023-01088-9

[49]

Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology 2003, 13, 41R-53R. DOI: 10.1093/glycob/cwg054

[50]

Packer RJ, Shrine N, Hall R, Melbourne CA, Thompson R, Williams AT, et al. Genome-wide association study of chronic sputum production implicates loci involved in mucus production and infection. Eur. Respir. J. 2023, 61, 2201667. DOI: 10.1183/13993003.01667-2022

[51]

Xie X, Kong S, Cao W. Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases. Front. Immunol. 2023, 14, 1168023. DOI: 10.3389/fimmu.2023.1168023

[52]

Saku A, Hirose K, Ito T, Iwata A, Sato T, Kaji H, et al. Fucosyltransferase 2 induces lung epithelial fucosylation and exacerbates house dust mite-induced airway inflammation. J. Allergy Clin. Immunol. 2019, 144, 698-709.e9. DOI: 10.1016/j.jaci.2019.05.010

[53]

Woodward AM, Guindolet D, Martinez-Carrasco R, Gabison EE, Lavker RM, Argüeso P. Low fucosylation defines the glycocalyx of progenitor cells and melanocytes in the human limbal stem cell niche. Stem Cell Rep. 2025, 20, 102378. DOI: 10.1016/j.stemcr.2024.11.008

[54]

Pan Q, Zhang XL. Roles of core fucosylation modification in immune system and diseases. Cell Insight 2025, 4, 100211. DOI: 10.1016/j.cellin.2024.100211

[55]

Hara N, Raclawska DS, Morgan LE, NeeDell JC, Dao L, Kato A, et al. Requirement for Fucosyltransferase 2 in Allergic Airway Hyperreactivity and Mucus Obstruction. Am. J. Respir. Cell Mol. Biol. 2025, 72, 408-417. DOI: 10.1165/rcmb.2024-0216OC

[56]

Liu Z, Meng X, Zhang Y, Sun J, Tang X, Zhang Z, et al. Author Correction: FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression. Int. J. Oral Sci. 2024, 16, 26. DOI: 10.1038/s41368-024-00307-x

[57]

Huang W, Yuan X, Lu J, Zhang S, Sun Y, Hang Y, et al. FUT8 promotes HDM-induced glycolysis, epithelial-mesenchymal transition and inflammation in bronchial epithelial cells by inducing N-glycosylation modification of GLUT1. Biochem. Biophys. Res. Commun. 2025, 786, 152721. DOI: 10.1016/j.bbrc.2025.152721

[58]

Blokland KEC, Pouwels SD, Schuliga M, Knight DA, Burgess JK. Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases. Clin. Sci. 2020, 134, 2681-2706. DOI: 10.1042/CS20190893

[59]

Herranz N, Gil J. Mechanisms and functions of cellular senescence. J. Clin. Investig. 2018, 128, 1238-1246. DOI: 10.1172/JCI95148

[60]

Sun W, Jing X, Yang X, Huang H, Luo Q, Xia S, et al. Regulation of the IGF1 signaling pathway is involved in idiopathic pulmonary fibrosis induced by alveolar epithelial cell senescence and core fucosylation. Aging 2021, 13, 18852-18869. DOI: 10.18632/aging.203335

[61]

Barnes PJ, Baker J, Donnelly LE. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. Am. J. Respir. Crit. Care Med. 2019, 200, 556-564. DOI: 10.1164/rccm.201810-1975TR

[62]

Liu RM, Liu G. Cell senescence and fibrotic lung diseases. Exp. Gerontol. 2020, 132, 110836. DOI: 10.1016/j.exger.2020.110836

[63]

Rivas M, Gupta G, Costanzo L, Ahmed H, Wyman AE, Geraghty P. Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease. Medicina 2022, 58, 817. DOI: 10.3390/medicina58060817

[64]

Ozdemir SA, Faizan MI, Kaur G, Shaikh SB, Ul Islam K, Rahman I. Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases. IJMS 2025, 26, 9687. DOI: 10.3390/ijms26199687

[65]

Minagawa S, Araya J, Numata T, Nojiri S, Hara H, Yumino Y, et al. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2011, 300, L391-L401. DOI: 10.1152/ajplung.00097.2010

[66]

Enomoto Y, Katsura H, Fujimura T, Ogata A, Baba S, Yamaoka A, et al. Autocrine TGF-β-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis. Nat. Commun. 2023, 14. DOI: 10.1038/s41467-023-40617-y

[67]

Ballester B, Milara J, Cortijo J. Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation. Oncotarget 2020, 11, 1306-1320. DOI: 10.18632/oncotarget.27526

[68]

Álvarez D, Cárdenes N, Sellarés J, Bueno M, Corey C, Hanumanthu VS, et al. IPF lung fibroblasts have a senescent phenotype. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2017, 313, L1164-L1173. DOI: 10.1152/ajplung.00220.2017

[69]

Wrench CL, Baker JR, Monkley S, Fenwick PS, Murray L, Donnelly LE, et al. Small airway fibroblasts from patients with chronic obstructive pulmonary disease exhibit cellular senescence. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2024, 326, L266-L279. DOI: 10.1152/ajplung.00419.2022

[70]

Zheng M, Yuan G, Han J, Li J, Jiang Y, Li Z, et al. FOXO1 contributes to cigarette smoke condensate-induced cellular senescence and fibrosis in lung fibroblasts through activating the TGF-β1/Smad2/3 signaling pathway. Immunol. Res. 2025, 73, 94. DOI: 10.1007/s12026-025-09646-1

[71]

Ishii M, Yamaguchi Y, Takada K, Hamaya H, Ogawa S, Akishita M. Effect of decreased expression of latent TGF-β binding proteins 4 on the pathogenesis of emphysema as an age-related disease. Arch. Gerontol. Geriatr. 2024, 127, 105597. DOI: 10.1016/j.archger.2024.105597

[72]

Noureddine H, Gary-Bobo G, Alifano M, Marcos E, Saker M, Vienney N, et al. Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease. Circ. Res. 2011, 109, 543-553. DOI: 10.1161/CIRCRESAHA.111.241299

[73]

Lehmann M, Hu Q, Hu Y, Hafner K, Costa R, van den Berg A, et al. Chronic WNT/β-catenin signaling induces cellular senescence in lung epithelial cells. Cell. Signal. 2020, 70, 109588. DOI: 10.1016/j.cellsig.2020.109588

[74]

Chen X, Xu H, Hou J, Wang H, Zheng Y, Li H, et al. Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. Aging 2019, 12, 242-259. DOI: 10.18632/aging.102613

[75]

Qiu T, Tian Y, Gao Y, Ma M, Li H, Liu X, et al. PTEN loss regulates alveolar epithelial cell senescence in pulmonary fibrosis depending on Akt activation. Aging 2019, 11, 7492-7509. DOI: 10.18632/aging.102262

[76]

Lee HS, Park HW. Role of mTOR in the Development of Asthma in Mice With Cigarette Smoke-Induced Cellular Senescence. J. Gerontol. Series A 2022, 77, 433-442. DOI: 10.1093/gerona/glab303

[77]

Zhang P, Jiang Y, Ye X, Zhang C, Tang Y. PDK1 inhibition reduces autophagy and cell senescence through the PI3K/AKT signalling pathway in a cigarette smoke mouse emphysema model. Exp. Ther. Med. 2023, 25, 223. DOI: 10.3892/etm.2023.11922

[78]

Xiaofei Y, Tingting L, Xuan W, Zhiyi H. Erythromycin attenuates oxidative stress-induced cellular senescence via the PI3K-mTOR signaling pathway in chronic obstructive pulmonary disease. Front. Pharmacol. 2022, 13, 1043474. DOI: 10.3389/fphar.2022.1043474

[79]

Cottage CT, Peterson N, Kearley J, Berlin A, Xiong X, Huntley A, et al. Targeting p16-induced senescence prevents cigarette smoke-induced emphysema by promoting IGF1/Akt1 signaling in mice. Commun. Biol. 2019, 2, 307. DOI: 10.1038/s42003-019-0532-1

[80]

Houssaini A, Breau M, Kebe K, Abid S, Marcos E, Lipskaia L, et al. mTOR pathway activation drives lung cell senescence and emphysema. JCI Insight 2018, 3, e93203. DOI: 10.1172/jci.insight.93203

[81]

Houssaini A, Marcos E, Gros V, Born E, Abid S, Rideau D, et al. Lung mTOR activation leads to lung fibrosis or emphysema via senescence of specific lung cells. Sci. Rep. 2026, 16, 13822. DOI: 10.1038/s41598-026-43628-z

[82]

Wang AP, Yang F, Tian Y, Su JH, Gu Q, Chen W, et al. Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension. Front. Physiol. 2021, 12, 656139. DOI: 10.3389/fphys.2021.656139

[83]

He B, Shao B, Cheng C, Ye Z, Yang Y, Fan B, et al. miR-21-Mediated Endothelial Senescence and Dysfunction Are Involved in Cigarette Smoke-Induced Pulmonary Hypertension through Activation of PI3K/AKT/mTOR Signaling. Toxics 2024, 12, 396. DOI: 10.3390/toxics12060396

[84]

Aoshiba K, Tsuji T, Kameyama S, Itoh M, Semba S, Yamaguchi K, et al. Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury. Exp. Toxicol. Pathol.y 2013, 65, 1053-1062. DOI: 10.1016/j.etp.2013.04.001

[85]

Zhu S, Zhou JQ, Wang K, Guo ML, Sanders YY. P38 MAPK is involved in epigenetic regulation of fibrotic genes in replication induced senescence in lung fibroblasts. Aging 2026, 18, 67-81. DOI: 10.18632/aging.206357

[86]

Zhou F, Onizawa S, Nagai A, Aoshiba K. Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury. Respir. Res. 2011, 12, 78. DOI: 10.1186/1465-9921-12-78

[87]

Milara J, Hernandez G, Ballester B, Morell A, Roger I, Montero P, et al. The JAK2 pathway is activated in idiopathic pulmonary fibrosis. Respir. Res. 2018, 19, 24. DOI: 10.1186/s12931-018-0728-9

[88]

Waters DW, Blokland KEC, Pathinayake PS, Wei L, Schuliga M, Jaffar J, et al. STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts. Am. J. Respir. Cell Mol. Biol. 2019, 61, 61-73. DOI: 10.1165/rcmb.2018-0328OC

[89]

Guo-Parke H, Cappa O, Linden DA, Barksby BS, Burgoyne RA, Borthwick LA, et al. IFN-Mediated Bronchial Epithelium Cellular Senescence in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Cell Mol. Biol. 2025, 73, 871-883. DOI: 10.1165/rcmb.2024-0453OC

[90]

Wu J, Dong F, Wang RA, Wang J, Zhao J, Yang M, et al. Central Role of Cellular Senescence in TSLP-Induced Airway Remodeling in Asthma. PLoS ONE 2013, 8, e77795. DOI: 10.1371/journal.pone.0077795

[91]

Tian Y, Li H, Qiu T, Dai J, Zhang Y, Chen J, et al. Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation. Aging Cell 2019, 18, e12858. DOI: 10.1111/acel.12858

[92]

Wu W, Wu X, Qiu L, Wan R, Zhu X, Chen S, et al. Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis. Naunyn-Schmiedeberg's Arch. Pharmacol. 2024, 397, 4809-4822. DOI: 10.1007/s00210-023-02913-8

[93]

Zhang Y, Do DC, Hu X, Wang J, Zhao Y, Mishra S, et al. CaMKII oxidation regulates cockroach allergen-induced mitophagy in asthma. J. Allergy Clin. Immunol. 2021, 147, 1464-1477.e11. DOI: 10.1016/j.jaci.2020.08.033

[94]

Li J, Hsu HC, Mountz JD, Allen JG. Unmasking Fucosylation: From Cell Adhesion to Immune System Regulation and Diseases. Cell Chem. Biol. 2018, 25, 499-512. DOI: 10.1016/j.chembiol.2018.02.005

[95]

Swaby C, Yeung-Luk B, Thapa S, Nishida K, Wally A, Ghosh B, et al. Decreased fucosylation impacts epithelial integrity and increases risk for COPD. bioRxiv 2023. DOI: 10.1101/2023.10.31.564805

[96]

Gu W, Chen Z, Yan R, Yang S, Hao C, Gao P. Elevated Fucosylation and the Role of Fut1 in Asthma: A Key Contributor to Abnormal Glycosylation in Airway Epithelial Cells. J. Allergy Clin. Immunol. 2025, 155, AB303. DOI: 10.1016/j.jaci.2024.12.934

[97]

Gu W, Zhang X, Wang Y, et al. Epithelial Fucosylation Drives Airway Barrier Dysfunction and Allergic Inflammation via a FUT1 -CDH12 Axis. Allergy 2026. DOI: 10.1111/all.70413.

[98]

Wu TJ, Wang SH, Chen ESW, Tsai HH, Chang YC, Tseng YH, et al. Loss of core-fucosylation of SPARC impairs collagen binding and contributes to COPD. Cell. Mol. Life Sci. 2022, 79, 348. DOI: 10.1007/s00018-022-04381-4

[99]

Gao C, Maeno T, Ota F, Ueno M, Korekane H, Takamatsu S, et al. Sensitivity of Heterozygous α1,6-Fucosyltransferase Knock-out Mice to Cigarette Smoke-induced Emphysema. J. Biol. Chem. 2012, 287, 16699-16708. DOI: 10.1074/jbc.M111.315333

[100]

Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, et al. Dysregulation of TGF-β1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl. Acad. Sci. USA 2005, 102, 15791-15796. DOI: 10.1073/pnas.0507375102

[101]

Yamada M, Ishii T, Ikeda S, Naka-Mieno M, Tanaka N, Arai T, et al. Association of fucosyltransferase 8 (FUT8) polymorphism Thr267Lys with pulmonary emphysema. J. Hum. Genet. 2011, 56, 857-860. DOI: 10.1038/jhg.2011.118

[102]

Sun Y, Sun W, Yang N, Liu J, Tang H, Li F, et al. The effect of core fucosylation-mediated regulation of multiple signaling pathways on lung pericyte activation and fibrosis. Int. J. Biochem. Cell Biol. 2019, 117, 105639. DOI: 10.1016/j.biocel.2019.105639

[103]

Zhang W, Lin W, Zeng X, Zhang M, Chen Q, Tang Y, et al. FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Aging Dis. 2023, 14, 1927. DOI: 10.14336/AD.2023.0218

[104]

Chen F, Lyu L, Xing C, Chen Y, Hu S, Wang M, et al. The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment. Front. Oncol. 2025, 15, 1649179. DOI: 10.3389/fonc.2025.1649179

[105]

Tominaga K, Suzuki HI. TGF-β Signaling in Cellular Senescence and Aging-Related Pathology. IJMS 2019, 20, 5002. DOI: 10.3390/ijms20205002

[106]

Hao Y, Baker D, ten Dijke P. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. IJMS 2019, 20, 2767. DOI: 10.3390/ijms20112767

[107]

Safwan-Zaiter H, Wagner N, Wagner KD . P16INK4A-More Than a Senescence Marker. Life 2022, 12, 1332. DOI: 10.3390/life12091332

[108]

Song B, Hu J, Chen S, Zhang Y. The Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma. BTT 2025, 19, 73-86. DOI: 10.2147/BTT.S497622

[109]

Liu Y, Kong H, Cai H, Chen G, Chen H, Ruan W. Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease. Front. Pharmacol. 2023, 14, 1238782. DOI: 10.3389/fphar.2023.1238782

[110]

Conduit SE, Vasan N, Brown JR, Perry MWD, Vanhaesebroeck B. A renaissance in targeting the PI3K/AKT/mTOR pathway. Nat. Rev. Drug Discov. 2026, 25, 469-493. DOI: 10.1038/s41573-026-01388-5

[111]

Davoodi-Moghaddam Z, Jafari-Raddani F, Delshad M, Pourbagheri-Sigaroodi A, Bashash D. Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials. J. Cancer Res. Clin. Oncol. 2023, 149, 15293-15310. DOI: 10.1007/s00432-023-05277-x

[112]

Jiang M, Zhang K, Zhang Z, Zeng X, Huang Z, Qin P, et al. PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. MedComm 2025, 6, e70295. DOI: 10.1002/mco2.70295

[113]

Yu M, Cui X, Wang H, Liu J, Qin H, Liu S, et al. FUT8 drives the proliferation and invasion of trophoblastic cells via IGF-1/IGF-1R signaling pathway. Placenta 2019, 75, 45-53. DOI: 10.1016/j.placenta.2018.11.005

[114]

Zhang C, Wu Q, Huang H, Chen X, Huang T, Li W, et al. Caveolin‐1 upregulates Fut8 expression by activating the Wnt/β‐catenin pathway to enhance HCC cell proliferative and invasive ability. Cell Biol. Int. 2020, 44, 2202-2212. DOI: 10.1002/cbin.11426

[115]

Vanhooren V, Dewaele S, Kuro‐o M, Taniguchi N, Dollé L, van Grunsven LA, et al. Alteration in N‐glycomics during mouse aging: a role for FUT8 . Aging Cell 2011, 10, 1056-1066. DOI: 10.1111/j.1474-9726.2011.00749.x

[116]

Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Sig. Transduct. Target. Ther. 2022, 7, 3. DOI: 10.1038/s41392-021-00762-6

[117]

Kurimoto A, Kitazume S, Kizuka Y, Nakajima K, Oka R, Fujinawa R, et al. The Absence of Core Fucose Up-regulates GnT-III and Wnt Target Genes. J. Biol. Chem. 2014, 289, 11704-11714. DOI: 10.1074/jbc.M113.502542

[118]

Hong S, Feng L, Yang Y, Jiang H, Hou X, Guo P, et al. In Situ Fucosylation of the Wnt Co-receptor LRP6 Increases Its Endocytosis and Reduces Wnt/β-Catenin Signaling. Cell Chem. Biol. 2020, 27, 1140-1150.e4. DOI: 10.1016/j.chembiol.2020.06.015

[119]

Ito E, Oka R, Ishii T, Korekane H, Kurimoto A, Kizuka Y, et al. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease. J. Proteom. 2015, 127, 386-394. DOI: 10.1016/j.jprot.2015.07.011

[120]

Nakanishi T, Cerani A, Forgetta V, Zhou S, Allen RJ, Leavy OC, et al. Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study. Eur. Respir. J. 2022, 59, 2003979. DOI: 10.1183/13993003.03979-2020

[121]

Wu Y, Hu L, Huang J, Zhong Y, Li K, Qiu Z, et al. N-glycomics profiling reveals alteration of fucosylation in early acute ischemic stroke from mouse brain tissue to human serum. Clin. Proteom. 2026, 23, 10. DOI: 10.1186/s12014-025-09578-w

[122]

Wu Y, Zhang Z, Chen L, Sun S. Immunoglobulin G glycosylation and its alterations in aging-related diseases. ABBS 2024, 56, 1221-1233. DOI: 10.3724/abbs.2024137

[123]

Paton B, Suarez M, Herrero P, Canela N. Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis. IJMS 2021, 22, 5788. DOI: 10.3390/ijms22115788

[124]

Gu Q, Wang Y, Zhu C, Zhou X, Ni L, Zhao H, et al. Immunoglobulin: unraveling its complex web in aging. Front. Immunol. 2025, 16, 1690018. DOI: 10.3389/fimmu.2025.1690018

PDF (1386KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/